Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16 860 patients

查看全文 作　　者：LI [1]Jing;CHEN Yi-[2]ping;LI [1]Xi;Jane [2]Armitage;FENG [1]Fang;LIU Jia-[1]min;GAO [1]Yan;ZHANG Hai-[1]bo;ZHANG [1]Dan;HUNDEI Wuhan-[1]bilige;CHEN Zheng-[2]ming;CHEN [2]Fang;Jemma C [2]Hopewell;Elsa Valdes-[2]Marquez;Martin [2]Landray;JIANG Li-[1]xin

机构地区：[1]China Oxford Centre for International Health Research, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;[2]Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford, Oxford, United Kingdom

出　　处：《Chinese Medical Journal》索引2012年第24期,共7页

关键词：动脉粥样硬化心血管疾病中国城市预防药物患者血管紧张素转换酶抑制剂二级横断面

相关文献

参考文献（32）
引证文献（10）
耦合文献（0）

参考文献(32)

引证文献(10)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16 860 patients

参考文献(32)

引证文献(10)

用户提示